You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JETREA

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vitreomacular Traction, Vitreomacular Adhesion Trial in New South Wales (Ocriplasmin 0.125 mg in a 0.1 mL volume)

Completed
Has Results
  • Vitreomacular Traction
  • Vitreomacular Adhesion
  • Ocriplasmin 0.125 mg in a 0.1 mL volume
  • New South Wales, Australia
    Contact Alcon Laboratories (Australia) for Trial Locations
Jul 23, 2018

Central Retinal Vein Occlusion Trial in Leuven (Ocriplasmin intravenously)

Completed
  • Central Retinal Vein Occlusion
  • Ocriplasmin intravenously
  • Leuven, Vlaams Brabant, Belgium
    UZ Leuven
Jan 4, 2018

Vitreomacular Traction, Vitreomacular Adhesion Trial (Ocriplasmin)

Completed
Has Results
  • Vitreomacular Traction
  • Vitreomacular Adhesion
  • (no location specified)
Aug 19, 2016

Symptomatic Vitreomacular Adhesion Trial in United States

Completed
  • Symptomatic Vitreomacular Adhesion
    • Phoenix, Arizona
    • +109 more
    Jun 20, 2016

    Patients Treated With Ocriplasmin for Symptomatic VMA

    Completed
    • Symptomatic Vitreomacular Adhesion (VMA)
      • Campbell, California
      • +23 more
      Jul 8, 2015